Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of switching to dolutegravir/lamivudine from tenofovir alafenamide fumarate/emtricitabine/dolutegravir or abacavir/lamivudine/dolutegravir on body weight and lipid profile in Japanese people living with HIV.
Ikegaya K, Muramatsu T, Sekiya R, Sekine Y, Harada Y, Miyashita R, Yamaguchi T, Ichiki A, Chikasawa Y, Bingo M, Yotsumoto M, Hagiwara T, Amano K, Takeuchi H, Kinai E. Ikegaya K, et al. Among authors: amano k. J Infect Chemother. 2024 Oct 22:S1341-321X(24)00291-5. doi: 10.1016/j.jiac.2024.10.012. Online ahead of print. J Infect Chemother. 2024. PMID: 39447868 Free article.
Long-term administration of pegylated liposomal doxorubicin at almost twice the recommended lifetime dose in 10 years without cardiotoxicity in a Japanese patient with HIV-associated Kaposi sarcoma.
Yokota K, Yotsumoto M, Muramatsu T, Saito M, Kamikubo Y, Ichiki A, Chikasawa Y, Bingo M, Hagiwara T, Amano K, Fukutake K. Yokota K, et al. Among authors: amano k. J Infect Chemother. 2020 Feb;26(2):289-291. doi: 10.1016/j.jiac.2019.08.016. Epub 2019 Sep 16. J Infect Chemother. 2020. PMID: 31537471
[Prevalence of chronic kidney disease among HIV-infected individuals in Japan--a report from two tertiary hospitals].
Muramatsu T, Yanagisawa N, Chikasawa Y, Seita I, Yotsumoto M, Otaki M, Ogata K, Hagiwara T, Suzuki T, Suganuma A, Imamura A, Amano K, Yamamoto Y, Nitta K, Ajisawa A, Fukutake K, Ando M. Muramatsu T, et al. Among authors: amano k. Kansenshogaku Zasshi. 2013 Jan;87(1):14-21. doi: 10.11150/kansenshogakuzasshi.87.14. Kansenshogaku Zasshi. 2013. PMID: 23484373 Japanese.
Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report.
Chikasawa Y, Hagiwara T, Bingo M, Amano K, Kikuchi S, Mitsuhashi A, Shinozawa K, Fukutake K, Kinai E. Chikasawa Y, et al. Among authors: amano k. Int J Hematol. 2022 Oct;116(4):622-629. doi: 10.1007/s12185-022-03372-2. Epub 2022 May 9. Int J Hematol. 2022. PMID: 35532874
1,357 results